Showing 1682 results
-
Press release /Kisqali is now the only CDK4/6 inhibitor indicated in combination with an aromatase inhibitor as first-line treatment for pre-, peri- or postmenopausal women with HR+/HER2- advanced breast cancer…
-
Press release /Kisqali plus an oral endocrine partner demonstrated significant efficacy with sustained benefit of nearly two years (median PFS 23.8 vs 13.0 months for endocrine therapy alone) and…
-
Story /Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.
-
Story /John Hadcock’s wife Laura gave him an ultimatum: Run the energy out of Sunny, the new puppy, or take her back to the breeder. So Hadcock started running. On his first trip out, he had to stop half a mile in.
-
Story /Dr. Matchaba describes how his unique background can help guide the company’s access-to-medicine efforts.
-
Story /The Chief Information Officer of the Novartis Institutes for BioMedical Research discusses his new role.
-
Story /At Novartis, we believe in the importance of balancing professional and personal responsibilities. This belief is embodied through our inclusive parental leave policy, which supports all our people in taking the time they need to be with their families during significant life events. To understand how this truly supports our colleagues we invited Sumeet, Global Head of Service Enablement & Governance, People Services & Solutions to share his story with us. -
Story /Caring for someone with heart failure can be both demanding and rewarding. Learn about the impact of being a carer and the support that carers need.
-
Story /A Cell & Gene production unit staffed by a highly trained team at Novartis will soon begin operating in Stein, Switzerland.
-
Story /Zebrafish imaging sheds light on human neurological conditions.